ReviewJournal of inflammation research2026
Regulatory T Cells in Diabetic Wound Healing: A Comprehensive Review.
Review in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with diabetes frequently face challenges associated with impaired wound healing, which is a serious clinical concern. Regulatory T cells (Tregs) are essential immune modulators that are integral to wound healing. While research is increasingly examining alterations in Tregs and their potential impacts on diabetic wound healing, a comprehensive review is lacking. This review employs a narrative approach to summarize the current knowledge regarding the mechanisms by which Tregs influence wound healing in diabetes, focusing on their impact on inflammatory responses, cellular regeneration, and angiogenesis. Furthermore, we investigated the potential therapeutic applications of Tregs in diabetic wound healing, highlighting recent advances in biomaterials, molecular pathways, and regulatory strategies targeting Tregs. Despite challenges such as cell acquisition and quality control, as well as risks like immunosuppression and infection, advancements in clinical studies indicate that Tregs could be a promising new treatment for diabetes. This review aims to provide novel insights and directions by analyzing the most recent literature on future therapeutic strategies for managing diabetic wounds.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.